Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

27 trials with published results (11%)

Research Maturity

147 completed trials (63% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.0%

7 terminated out of 235 trials

Success Rate

95.5%

+8.9% vs benchmark

Late-Stage Pipeline

9%

20 trials in Phase 3/4

Results Transparency

18%

27 of 147 completed with results

Key Signals

27 with results95% success

Data Visualizations

Phase Distribution

171Total
Not Applicable (125)
Early P 1 (1)
P 1 (9)
P 2 (16)
P 3 (12)
P 4 (8)

Trial Status

Completed147
Recruiting30
Unknown22
Active Not Recruiting12
Not Yet Recruiting11
Terminated7

Trial Success Rate

95.5%

Benchmark: 86.5%

Based on 147 completed trials

Clinical Trials (235)

Showing 20 of 20 trials
NCT00024635RecruitingPrimary

Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers

NCT07708168Not ApplicableNot Yet RecruitingPrimary

MyFILM: A Pilot Study for Social-Emotional Learning in Clinical Youth

NCT06376734Phase 2Recruiting

Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness

NCT00397111RecruitingPrimary

Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders

NCT06282146Early Phase 1Completed

Testing a Transdiagnostic TMS Treatment Target

NCT06408012RecruitingPrimary

An Innovative Master Platform for Clinical Trials in Mood Disorders

NCT06511908Phase 2Recruiting

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

NCT06341426Phase 2Active Not Recruiting

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin

NCT05680727Phase 2Completed

Individualized Functional Connectivity Targeting in aiTBS for Depression

NCT07155707Not ApplicableRecruiting

Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

NCT06144294Not ApplicableNot Yet Recruiting

Whole-Body Hyperthermia for Mood and Anxiety Disorders

NCT00071786CompletedPrimary

Family Study of Affective and Anxiety Spectrum Disorders

NCT05345392Not ApplicableActive Not RecruitingPrimary

Brain, Emotions, and Mind-Wandering

NCT05658796Not ApplicableRecruitingPrimary

RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty

NCT05656469Not ApplicableRecruitingPrimary

Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders

NCT03458936Active Not Recruiting

Resilience in Adolescent Development

NCT04358900CompletedPrimary

Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)

NCT06929442Not ApplicableRecruiting

A Preventive Behavioral Intervention for Young Adults With Psychotic Experiences

NCT06360562Not ApplicableActive Not RecruitingPrimary

Reconnecting to Ourselves and Others in Virtual Meetings (ROOM)

NCT07088939Not ApplicableRecruiting

Feasibility and Acceptability of an E-learning Dialectical Behavior Therapy Skills Course

Scroll to load more

Research Network

Activity Timeline